Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Viemed Healthcare
VMD
Viemed Healthcare
Medicare Pressures And Competition Will Test Margins Yet Improve Resilience
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
29 May 25
Updated
16 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$11.00
37.4% undervalued
intrinsic discount
16 Aug
US$6.89
Loading
1Y
-5.7%
7D
-5.5%
Author's Valuation
US$11.0
37.4% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$11.0
37.4% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
400m
2014
2017
2020
2023
2025
2026
2028
Revenue US$400.0m
Earnings US$27.9m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
16.72%
Healthcare Services revenue growth rate
0.27%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.78%
Calculation
US$27.95m
Earnings '28
x
18.21x
PE Ratio '28
=
US$508.86m
Market Cap '28
US$508.86m
Market Cap '28
/
38.67m
No. shares '28
=
US$13.16
Share Price '28
US$13.16
Share Price '28
Discounted to 2025 @ 6.78% p.a.
=
US$10.81
Fair Value '25
